Cordyceps Sunshine Biotech Holdings (RAJAF) Invested Capital (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Invested Capital history runs 6 years deep, the most recent figure standing at -$69318.0 for Q4 2025.

• In Q4 2025, Invested Capital fell 195.46% year-over-year to -$69318.0; the TTM figure through Dec 2025 stood at -$69318.0 (down 195.46% YoY), while the FY2025 annual figure was -$69318.0, down 195.46% from the prior year.
• Invested Capital was -$69318.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, down from $72612.0 in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.3 million in Q4 2021 to a low of -$537334.0 in Q4 2022.
• Historically, Invested Capital has averaged $71116.0 across 5 years, with a median of -$110557.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Invested Capital surged 147.84% in 2024, then slumped 195.46% in 2025.
• A 5-year view of Invested Capital shows it stood at $1.3 million in 2021, then sank by 141.48% to -$537334.0 in 2022, then surged by 71.75% to -$151796.0 in 2023, then soared by 147.84% to $72612.0 in 2024, then plunged by 195.46% to -$69318.0 in 2025.
• The last three Invested Capital figures came in at -$69318.0 (Q4 2025), $72612.0 (Q4 2024), and -$151796.0 (Q4 2023), per Business Quant data.